Cargando…

Rapid progression of disease from immunotherapy following targeted therapy: insights into treatment management and sequence

With emerging promising therapeutic regimens in non-small cell lung cancer (NSCLC), the standard-of-care treatments for a variety of histologic and mutated subgroups in NSCLC has been regularly shifting in response to landmark clinical trials. However, with the availability of a range of therapeutic...

Descripción completa

Detalles Bibliográficos
Autores principales: Pharaon, Rebecca, Mambetsariev, Isa, Fricke, Jeremy, Salgia, Ravi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7578509/
https://www.ncbi.nlm.nih.gov/pubmed/33145086
http://dx.doi.org/10.21037/jtd.2019.08.14